Nalaganje...
Potential role of daratumumab in the treatment of multiple myeloma
Multiple myeloma is the second most common hematologic malignancy in the US. Treatments utilizing alkylating agents, corticosteroids, proteasome inhibitors, and immunomodulatory drugs have resulted in significant survival benefits, however, despite the advances, relapse is inevitable. Decreased dept...
Shranjeno v:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2014
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4069139/ https://ncbi.nlm.nih.gov/pubmed/24971019 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S49480 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|
Nalaganje...